APL-9796

· Apollo Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APL-9796, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of "APL-9796'' in Adults With Pulmonary Hypertension [Phase 2]